author-photo

Virna B. Borowski

Johnson & Johnson Pharmaceutical Research and Development

1

Papers

7

Citations

Citation Trend

Filter By

Papers (1) Sort By

Journal Conference Others

A highly selective, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor has potent activity in vitro and in vivo

2009 Angiogenesis
Show All
- Source
- Cite
- Save
Citations (7)